Nature10mon
Recombinant protein therapeutics—success rates, market trends and values to 2010
We find that, as the biotechnology industry developed ... New Brunswick, NJ, USA) was the top-selling protein, with sales of $3,430m in 2001, $4,269m in 2002 and $3,986m in 2003, while the ...
Is Apellis Pharmaceuticals, Inc. (APLS) a Promising Biotech Stock According to Wall Street Analysts
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
Endpoints News10d
George Church spin­out de­vel­op­ing ge­nom­i­cal­ly re­cod­ed or­gan­isms cuts most em­ploy­ees
GRO Biosciences, a small but ambitious biotech startup attempting to create novel protein drugs from genetically modified bacteria, has cut most of its staff after “efficacy issues” delayed its ...
Vietnam Investment Reviev16d
Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women
Targeted Biotech USA, Inc. has achieved remarkable results in the field of early cancer screening. Its core product, the E7 protein home self-test kit, fills a gap in the world and has successfully ...
Bioengineered Protein Drugs Market Size To Cross USD 672.7 Billion By 2034, Growing At A CAGR Of 6.2% - Report By Transparency Market Research, Inc.
The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...